Christian Dougherty Joins Objective Capital Partners As Managing Director, Valuation

Posted March 21, 2019 by OCP | Post a Comment

We are pleased to announce the addition of Christian Dougherty to the Objective Capital Partners team. In his role as Managing Director of the Valuation Practice, Christian adds invaluable experience and successful leadership to our team of professionals. His world class ability to serve clients and deep access in our industries of focus make him an outstanding addition to OCP’s senior team. With a proven ability to deliver a portfolio of valuation services to clients from San Diego to New York, Chris further strengthens Objective Capital’s Valuation Practice.

(more…)

Valuation, Blog Article, OCP News

Objective Capital Partners Completes Sale of Carl Warren to Claims Technology Group of America, Inc.

Posted March 14, 2019 by OCP | Post a Comment
San Diego, CA and Orange County, CA, March 14, 2019 - Objective Capital Partners, a leading middle market investment banking firm located in Southern California and focused on mergers & acquisitions (M&A), capital raising, valuation and strategic advisory services, is pleased to announce that it served as the exclusive financial advisor to Carl Warren, a Third Party Administrator (TPA) specializing in liability and property claims management and subrogation services, on its sale to Claims Technology Group of America, Inc.
(more…)

OCP News, Sell-Side M&A

How To Navigate Investment Banking Fees

Posted February 25, 2019 by OCP | Post a Comment
If you are a business owner contemplating the sale of your business, there is one primary question that tends to arise: How do investment banking fees work? An investment banker’s expertise can often significantly increase the sale price and raise the probability of completing a successful transaction. However, before getting started with an investment bank, you want a clear understanding of what fees to expect.
 
(more…)

Investment banking, Blog Article, OCP News

Matthew J. Pelo Joins Objective Capital Partners As Vice President

Posted February 11, 2019 by OCP | Post a Comment

Objective Capital Partners is pleased to announce the addition of Matthew Pelo to the OCP team. In his role as Vice President, Matt brings valuable strategic insights and finance expertise to OCP’s clients. His leadership experience and extensive work in the areas of Genomics and Technology make him an outstanding addition to OCP’s senior team and further strengthen OCP’s Life Sciences and Healthcare Practice Group. With a proven ability to achieve exceptional results, Matt further enhances OCP’s ability to deliver premium investment banking and advisory services to our valued clients.

(more…)

Healthcare, Life Sciences, Blog Article, OCP News

NanoIVD, Inc. Retains Objective Capital Partners to Explore Strategic and Financial Partnerships

Posted January 31, 2019 by OCP | Post a Comment

San Diego, CA and Los Angeles, CA, January 31, 2019 — NanoIVD, Inc., a privately-held company, working on advancing scientific discoveries and understanding of cancer and Alzheimer’s disease for the purpose of diagnosis and treatment, has retained Objective Capital Partners, a middle-market Investment Banking firm located in Southern California and focused on strategic advisory, mergers & acquisitions (M&A), capital financing and valuation services, as their financial advisor.  Objective Capital Partners will seek to identify strategic partnerships and financial investors for NanoIVD to progress the development of their novel work. 

(more…)

OCP News

Objective Capital Partners Announced as Finalist for the Valuation Firm of The Year in the 17th Annual M&A Advisor Awards

Posted September 18, 2018 by OCP | Post a Comment

San Diego, September 14, 2018 – Objective Capital Partners, a leading middle-market M&A firm, has been nationally recognized as a Valuation Firm of the Year Award finalist by M&A Advisor for their valuation work in Life Sciences, Healthcare, and Technology.

(more…)

OCP News

OCP Is Leading Growth in the San Diego Life Science Community

Posted June 04, 2018 by OCP | Post a Comment

"Working with life science companies is not like serving other industries. There are myriad legal and financial eccentricities - accounting for multiple financing sources makes accounting especially complex, for instances and protecting intellectual property is key. Early-stage companies may need their hand held as they focus on the science and outsource everything else." San Diego Business Journal

(more…)

Business Valuation, Healthcare, Life Sciences, OCP News, Capital Raise & Financing, Strategic Advisory

Objective Capital Partners Welcomes Matt Ramirez as Associate

Posted May 10, 2018 by OCP | Post a Comment

We are excited to announce the addition of experienced finance professional, Matt Ramirez, to the firm. Matt brings with him a great depth of finance experience having served previously as a Senior Associate with Ernst & Young's Assurance Services Practice where he led teams in the execution of public and private company financial statement audits.

(more…)

OCP News

Objective Capital Advises Healthcare IT Company on Its Sale to Kinderhook Industries

Posted May 01, 2018 by OCP | Post a Comment

Los Angeles, CA April 24, 2018 — Objective Capital Partners, a leading middle market investment banking firm, is pleased to announce that it served as the exclusive financial advisor to StudyKIK LLC, a rapidly-growing healthcare IT company, on its acquisition by Kinderhook Industries LLC.

“Matt and his team have done a remarkable job in creating a leading patient recruiting platform which is having an enormous impact by making it dramatically more efficient for clinical trial companies to find and engage the high-fit trial volunteers they need to bring new and innovative treatments to market,” said Channing Hamlet, Managing Director of Objective Capital Partners. “We are privileged to have had this opportunity to help StudyKIK and couldn’t be more excited about the future of the company.”

(more…)

Healthcare, Life Sciences, OCP News, Strategic Advisory

Symple Surgical, Inc. Retains Objective Capital Partners to Explore Strategic and Financial Partnerships

Posted April 17, 2018 by OCP | Post a Comment

San Diego, CA and Flagstaff, AZ, April 12, 2018: — Symple Surgical, Inc., a privately-held, early-stage medical device company focused on developing novel therapeutic technologies using microwave technology for treatment of life-threatening chronic conditions, is pleased to the announce that they have retained Objective Capital Partners as their exclusive financial advisor. Objective Capital Partners, a middle-market Investment Banking firm located in Southern California and focused on mergers & acquisitions (M&A), strategic advisory, capital financing and valuation services, will seek to identify strategic partnerships and financial investors for the Company to progress their lead product Grizzly™ targeting pre-cancerous cells in the elimination of Barrett's Esophagus and Esophageal Adenocarcinoma, the fastest growing cancer worldwide.

Barrett’s Esophagus (BE) is a premalignant condition caused by stomach acid or gastrointestinal reflux disease (GERD) mutating healthy cells in the lower esophagus into Barrett’s cells.  Approximately 90% of Esophageal Adenocarcinoma (EAC) patients do not receive a prior diagnosis of Barrett’s Esophagus (BE). BE affect’s more than 12 million American adults, and is associated with a 30-fold increased risk of developing EAC. This new treatment will provide an alternative to the Radiofrequency Ablation Technology (“RFA”) and cryoablation technologies currently in use for treatment of BE thereby reducing the number of episodes of treatment and providing unparalleled user control for adequate cell removal.

(more…)

Healthcare, Life Sciences, OCP News, Strategic Advisory

This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

Our Services

Learn about our services and how we can help you sell your business successfully.

LEARN MORE

Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone
trever.acers@objectivecp.com

Channing Hamlet
Managing Director
858.342.4939 telephone
channing.hamlet@objectivecp.com

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone
david.crean@objectivecp.com

Jack J. Florio
Managing Director
858.864.4339 telephone
jack.florio@objectivecp.com